PHARMACIA AND UPJOHN FDA Approval NDA 017968

NDA 017968

PHARMACIA AND UPJOHN

FDA Drug Application

Application #017968

Application Sponsors

NDA 017968PHARMACIA AND UPJOHN

Marketing Status

Discontinued001

Application Products

001INJECTABLE;INJECTION2MG/ML;50MG/ML0DEPO-TESTADIOLESTRADIOL CYPIONATE; TESTOSTERONE CYPIONATE

FDA Submissions

TYPE 5; Type 5 - New Formulation or New ManufacturerORIG1AP1980-06-13STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1982-04-15STANDARD
LABELING; LabelingSUPPL3AP1985-06-28STANDARD
LABELING; LabelingSUPPL5AP1993-05-10STANDARD
LABELING; LabelingSUPPL6AP1996-02-22STANDARD
LABELING; LabelingSUPPL7AP1994-07-15STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL8AP2000-04-03STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL9AP2002-05-23STANDARD

Submissions Property Types

ORIG1Null0
SUPPL2Null0
SUPPL3Null0
SUPPL5Null0
SUPPL6Null0
SUPPL7Null0
SUPPL8Null0
SUPPL9Null0

CDER Filings

PHARMACIA AND UPJOHN
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 17968
            [companyName] => PHARMACIA AND UPJOHN
            [docInserts] => ["",""]
            [products] => [{"drugName":"DEPO-TESTADIOL","activeIngredients":"ESTRADIOL CYPIONATE; TESTOSTERONE CYPIONATE","strength":"2MG\/ML;50MG\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"DEPO-TESTADIOL","submission":"ESTRADIOL CYPIONATE; TESTOSTERONE CYPIONATE","actionType":"2MG\/ML;50MG\/ML","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.